Tetra Tech (TTEK) Q1 2026 earnings review
Shrink-to-Grow: Margins Expand as Revenue Resets
Tetra Tech's Q1 results illustrate a company in the middle of a radical structural reset. Following the exit of massive USAID contracts in FY25, reported Net Revenue fell 13% YoY to $1.04B. However, management successfully protected the bottom line: Adjusted EBITDA margins expanded 140 basis points, and Adjusted EPS held flat at $0.35 (or up 17% if excluding the lost USAID contribution from the prior year). The company raised full-year guidance, driven partly by post-quarter acquisitions (Halvik, Providence), signaling that the revenue trough may be behind them.
🐂 Bull Case
The strategic shift away from low-margin USAID pass-through work is working. Adjusted EBITDA margin expanded 140 basis points YoY. As the mix shifts further toward high-end consulting and data analytics (Halvik acquisition), profitability per dollar of revenue is increasing.
Management raised FY26 Net Revenue guidance to $4.15B-$4.30B (from $4.05B-$4.25B) and EPS to $1.46-$1.56. Two strategic acquisitions announced post-quarter (Halvik, Providence) immediately bolster the backlog and add capabilities in defense and data analytics.
🐻 Bear Case
Despite management's 'Ex-USAID' growth narrative, the reality is the company is shrinking. GAAP Revenue fell 15% and Net Revenue fell 13% YoY. Backlog dropped to $3.95B from $4.14B in the preceding quarter, indicating the organic business hasn't yet fully filled the hole left by contract exits.
Management's claim of '17% EPS growth' relies on excluding the profitable (albeit low margin) USAID contributions from the prior year base. On a reported adjusted basis, EPS was flat YoY ($0.35 vs $0.35). The growth quality is currently engineered rather than organic.
⚖️ Verdict: ⚪
Neutral/Hold. The margin story is excellent, and the balance sheet is healthy. However, the 13% drop in Net Revenue and sequential decline in backlog (pre-acquisitions) show that the organic pivot is still messy. The guidance raise is a positive signal, but relies on M&A to generate growth.
Key Themes
The 'Ex-USAID' Growth Narrative vs. Reality
Management claims Net Revenue is 'up 8%' and EPS 'up 17%,' but these figures exclude the massive USAID/DOS contracts held in the prior year. On a GAAP basis, Net Revenue collapsed 13% ($1.20B to $1.04B). Investors must differentiate between the *remaining* business (which is growing ~3-8%) and the *total* business (which is shrinking significantly). This distortion will persist until FY26 Q2 laps the exits.
Acquisitions to Plug the Gap
Subsequent to Q1, TTEK announced acquiring Halvik (data analytics/cybersecurity) and Providence (advisory). This is a critical pivot. Halvik specifically targets high-margin defense and intel work. The raised FY26 guidance likely incorporates these inorganic contributions, masking continued organic softness in the core backlog.
Backlog Erosion
Decelerating. Backlog ended Q1 at $3.95 billion, down sequentially from $4.14 billion in Q4 FY25 and $4.09 billion in Q2 FY25. While management cites a $151 billion contract ceiling award (IDIQ) for missile defense, IDIQs do not immediately translate to funded backlog. The sequential dip suggests book-to-bill was below 1.0x in the quarter.
Capital Return Acceleration
Accelerating. The Board approved a 12% dividend hike ($0.065/share) and repurchased $50 million in stock in Q1 (vs $25 million in prior quarters). With $548 million remaining on the authorization and cash flow improving (DSO down to 51 days), TTEK is using its balance sheet to support the stock during this revenue transition.
Defense & Data Center Pivot
The narrative is shifting aggressively toward Defense and Commercial Power. Highlights include a $151B ceiling IDIQ for Missile Defense and commercial power projects for energy demand. The Halvik acquisition reinforces the move into 'resilient infrastructure' and data analytics, moving further away from traditional low-tech environmental remediation.
Other KPIs
Reversing. Down 13.4% YoY from $1.197 billion. While 'Ex-USAID' revenue grew, the aggregate top-line contraction confirms the scale of the business reset is still impacting headline numbers.
Accelerating. Management cited a 140 bps improvement YoY. This validates the thesis that shedding revenue would improve quality. The shift to fixed-price and high-end consulting is flowing through to profitability.
improving. Down from 55.9 days a year ago. This is a strong indicator of working capital efficiency, likely aided by the exit of slower-paying government aid contracts.
Guidance
Raised. Previous guidance was $4.05 - $4.25 billion. The raise ($100M at low end) likely accounts for the Halvik and Providence acquisitions. Implied YoY growth is still negative (-7% to -10%) versus FY25 Actuals (~$4.6B), but the trajectory is improving.
Raised. Previous guidance was $1.40 - $1.55. The midpoint ($1.51) represents a decline from FY25 Adjusted EPS of $1.56, again reflecting the lost volume. However, the raise suggests the margin accretion from recent deals is better than initially modeled.
Decelerating. The midpoint ($1.0B) implies a sequential decline from Q1's $1.037B. This contradicts the 'growth' narrative and suggests the acquisition contributions might not fully hit until H2, or organic softness persists.
Key Questions
Organic vs. Inorganic Guidance Raise
You raised FY26 Net Revenue guidance by ~$50-100M. How much of this raise is solely attributable to the Halvik and Providence acquisitions versus organic outperformance in the legacy business?
Backlog Sequential Decline
Backlog dropped sequentially to $3.95B from $4.14B in Q4. Given the emphasis on 'Ex-USAID growth' and the new IDIQ wins, why is the funded backlog contracting sequentially? Does this figure include acquired backlog from Halvik?
Net Revenue Reconciliation
You cited 'Net Revenue up 8%' in the highlights, yet the table shows Net Revenue Ex-USAID growing only ~2.9% ($986M vs $959M). Can you bridge this gap? Is there a currency impact or specific adjustment driving the 8% figure?
Q2 Sequential Step-Down
Q2 Net Revenue guidance ($1.0B midpoint) is lower than Q1 actuals ($1.04B). Is this purely seasonality, or are there remaining contract run-offs expected in Q2?
Commercial Segment Health
In prior quarters, Commercial renewables were a headwind. Has the Commercial/Industrial Group (CIG) returned to organic growth this quarter, or is the 8% growth figure driven entirely by Government Services?